文献速递神经儿科影像MRCT

Aicardi-Goutières综合征:来自中东病例系列的认识

Aicardi-Goutières Syndrome: Insights from a Middle Eastern Case Series.
PubMed 文献 · AJNR Am J Neuroradiol · 2026-07-01

该研究回顾性分析卡塔尔一家三级儿科医院2016年11月至2024年12月管理的15例基因确诊Aicardi-Goutières综合征(AGS)病例,描述其临床、影像和遗传特征。影像学提示该病者仅占40%,初始神经影像以局灶性白质病变(76.9%)、钙化(53.8%)、髓鞘化延迟(38.5%)和基底节受累(30.8%)为主;基因型与初诊时白质病变严重程度显著相关(P<.05),但与纵向影像演变无关,家族内影像不一致见于半数家系。

要点

  • AGS初始神经影像以局灶性白质病变(76.9%)和钙化(53.8%)最常见,但影像学提示该病者仅40%。
  • 白质病变严重程度与基因型显著相关(P<.05),但随访影像演变与基因型及临床病程无关。
  • 家族内影像表现不一致见于半数家系,报告时需结合基因与临床综合判断。

核心结论

  • 该中东人群AGS系列拓宽了表型谱,突出高度近亲婚配人群中的高纯合率和RNASEH2基因 predominance,基因型与白质病变严重程度显著相关,而影像学变异性独立于基因型或临床病程。

研究设计与样本

  • 回顾性病例系列,纳入卡塔尔一家三级儿科医院2016年11月至2024年12月管理的15例基因确诊AGS病例,提取人口学、临床、影像和遗传数据,对白质病变严重程度和影像病程进行分级,并探索与基因型的关联。

关键影像表现/征象

  • 初始神经影像显示局灶性白质病变76.9%、钙化53.8%、髓鞘化延迟38.5%、基底节受累30.8%。
  • 白质病变程度为无13.3%、轻度40.0%、中度40%、重度6.7%。
  • 随访影像显示影像表现稳定10%、消退30%、进展40%、先进展后消退20%。

诊断标准与关键数值

  • 影像学评估提示该病者占40%。
  • 基因型与初诊时白质病变严重程度显著相关(P<.05),与纵向影像演变无显著相关。

临床应用与阅片要点

  • 初始神经影像见局灶性白质病变、钙化、髓鞘化延迟或基底节受累时,应将AGS纳入鉴别诊断。
  • 影像学提示该病者仅40%,报告时需结合基因检测和临床特征综合判断。
  • 家族内影像表现不一致见于半数家系,同一家系不同患者的影像严重程度和演变可能不同。

局限性

  • 本文为回顾性病例系列。
  • 样本量为15例。
  • 单中心来自卡塔尔一家三级儿科医院。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Aicardi-Goutières syndrome (AGS) is a rare, genetically-determined spectrum of neurodegenerative disorders that remains poorly understood. Owing to the paucity of data from the Middle Eastern population, we aimed to delineate the clinical, radiologic, and genetic features of AGS in an under-represented Middle Eastern cohort.

MATERIALS AND METHODS: A retrospective case series review was performed of all genetically-confirmed AGS cases managed at a tertiary pediatric hospital in Qatar between November 2016 and December 2024. Demographic, clinical, radiologic, and genetic data were extracted; WM disease severity and imaging course were graded, and associations with genotype were explored.

RESULTS: Fifteen individuals (73.3% male; 80% consanguinity) were identified. Symptom onset occurred in the infantile age in 86.7%, with developmental delay or regression (100%), intellectual impairment (76.9%), and impaired motor function (69.2%) predominating. Two siblings with a SAMHD1-homozygous variant were neurologically normal but had chronic arthritis. Genetic variants were identified in RNASEH2B (26.7%), RNASEH2A, and TREX1 (each 20%), followed by ADAR1 and SAMHD1 (each 13.3%), and RNASEH2C (6.7%); 80% of variants were homozygous. Radiologic assessment was suggestive of the disease in 40% of the cases. Initial neuroimaging revealed focal WM disease in 76.9%, calcifications in 53.8%, hypomyelination in 38.5%, and basal ganglia involvement in 30.8%. WM disease was absent (13.3%), mild (40.0%), moderate (40%), or severe (6.7%); follow-up imaging showed stable (10%), regressive (30%), progressive (40%), or progressive-then-regressive (20%) course of imaging findings, independent of the genotype and clinical course. Genotype correlated significantly with WM disease severity at presentation (P < .05), but not with longitudinal imaging trajectory. Intrafamilial radiologic discordance was observed in one-half of the family clusters.

CONCLUSIONS: This AGS series from a Middle Eastern population broadens the phenotypic spectrum, highlighting high homozygosity and RNASEH2 predominance in a highly consanguineous population, a significant genotype-WM disease severity link, and radiologic variability independent of genotype or clinical course. Awareness of these patterns may inform population-based testing and management strategies.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Alwalid O, Al Subhi M, Al Serhan AA, et al. Aicardi-Goutières Syndrome: Insights from a Middle Eastern Case Series. AJNR Am J Neuroradiol. 2026. PMID: 41839614. doi:10.3174/ajnr.A9239

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。